Comments for MedNews Africa http://www.mednewsafrica.com Quick Access to Medical Journals , Latest News, Alerts Sat, 05 Nov 2011 00:49:17 +0000 hourly 1 Comment on Male circumcision for HIV prevention: current evidence and implementation in sub-Saharan Africa by Hugh7 http://www.mednewsafrica.com/2011/11/male-circumcision-for-hiv-prevention-current-evidence-and-implementation-in-sub-saharan-africa/#comment-1426 Hugh7 Sat, 05 Nov 2011 00:49:17 +0000 http://www.mednewsafrica.com/?p=4984#comment-1426 The same few researchers have been driving the push to circumcise all boys everywhere for years. It’s hard to find a pro-circumcision paper that does not have the name of Robert Bailey, Stefan Bailis, Ronald Gray, Daniel Halperin, Godfrey Kigozi, Jeffrey Klausner, Brian Morris, Stephen Moses, Malcolm Potts, Thomas Quinn, Edgar Schoen, Maria Wawer, Helen Weiss, and/or Thomas Wiswell on it. (Halperin has said he’s “destined” to promote it by his descent from a ritual circumciser. Morris has co-authored a paper with the editor of circumcision-fetish website, and thinks infant circumcision should be “mandatory” in Australia. Schoen has written poems in praise of circumcision.) Of the list above, this "news" was authored by Morris, Bailis and Klausner. Cutting genitals, especially thosse of infants, is an anomalous way of preventing a sexually transmitted disease of adults, and it is the compulsion to do it that should be investigated. The same few researchers have been driving the push to circumcise all boys everywhere for years. It’s hard to find a pro-circumcision paper that does not have the name of Robert Bailey, Stefan Bailis, Ronald Gray, Daniel Halperin, Godfrey Kigozi, Jeffrey Klausner, Brian Morris, Stephen Moses, Malcolm Potts, Thomas Quinn, Edgar Schoen, Maria Wawer, Helen Weiss, and/or Thomas Wiswell on it. (Halperin has said he’s “destined” to promote it by his descent from a ritual circumciser. Morris has co-authored a paper with the editor of circumcision-fetish website, and thinks infant circumcision should be “mandatory” in Australia. Schoen has written poems in praise of circumcision.)

Of the list above, this “news” was authored by Morris, Bailis and Klausner. Cutting genitals, especially thosse of infants, is an anomalous way of preventing a sexually transmitted disease of adults, and it is the compulsion to do it that should be investigated.

]]> Comment on Efficacy of PermaNet(R) 2.0 and PermaNet(R) 3.0 against insecticide-resistant Anopheles gambiae in experimental huts in Cote d’Ivoire by Rune Bosselmann http://www.mednewsafrica.com/2011/07/efficacy-of-permanetr-2-0-and-permanetr-3-0-against-insecticide-resistant-anopheles-gambiae-in-experimental-huts-in-cote-divoire/#comment-1039 Rune Bosselmann Wed, 20 Jul 2011 14:42:43 +0000 http://www.mednewsafrica.com/?p=3986#comment-1039 I would like to invite the distinguished readers to participate to debating this article in particular and the approach of Permanet 3.0 to resistance in general on malaria world http://malariaworld.org/forum/pouring-gasoline-insecticide-resistance-fire thanks I would like to invite the distinguished readers to participate to debating this article in particular and the approach of Permanet 3.0 to resistance in general on malaria world

http://malariaworld.org/forum/pouring-gasoline-insecticide-resistance-fire

thanks

]]> Comment on Ebola by katz http://www.mednewsafrica.com/ebola/#comment-781 katz Mon, 16 May 2011 14:38:23 +0000 http://www.wadn.org/africa/?page_id=84#comment-781 HUMAN EBOLA AND MARBURG CLINCAL TRAILS HAPPENING THIS WEEK IN THE U.S. The purpose of this study is to characterize the safety and pharmacology of single administrations of AVI-6002, a post-exposure prophylaxis candidate treatment for Ebolavirus. Clinical Trial Conditions: Ebola Hemorrhagic Fever Treatments in this Clinical Trial : Placebo, AVI-6002 Clinical Trial Phase: Phase 1 Eligible Clinical Trial Participant Age : Between 18 years to 50 years Can Healthy Volunteers Participate: Yes Clinical Trial Lead Sponsor: AVI BioPharma, Inc. Detailed Clinical Trial Description: The purpose of this study is to characterize the safety and pharmacology of single administrations of AVI-6002, a post-exposure prophylaxis candidate treatment for Ebolavirus. The clinical trial information was obtained from http://clinicaltrials.gov/ct2/show/NCT01353027 Safety Study of Single Administration Post-Exposure Prophylaxis Treatment for Ebola Virus http://www.clinicaltrials.gov/ct2/show/NCT01353027?term=AVI+BIOPHARMA&rank=4 A similar trial with AVI-6003 to treat infection with the Marburg virus is being conducted at West Coast Clinical Trials in Cypress, California. http://www.clinicaltrials.gov/ct2/show/NCT01353040?term=AVI+BIOPHARMA&rank=3 Uganda: Deadly Ebola Virus Confirmed Near Capital HUMAN EBOLA AND MARBURG CLINCAL TRAILS HAPPENING THIS WEEK IN THE U.S.

The purpose of this study is to characterize the safety and pharmacology of single
administrations of AVI-6002, a post-exposure prophylaxis candidate treatment for Ebolavirus.
Clinical Trial Conditions: Ebola Hemorrhagic Fever
Treatments in this Clinical Trial : Placebo, AVI-6002
Clinical Trial Phase: Phase 1
Eligible Clinical Trial Participant Age : Between 18 years to 50 years
Can Healthy Volunteers Participate: Yes
Clinical Trial Lead Sponsor: AVI BioPharma, Inc.
Detailed Clinical Trial Description: The purpose of this study is to characterize the safety and pharmacology of single
administrations of AVI-6002, a post-exposure prophylaxis candidate treatment for Ebolavirus.
The clinical trial information was obtained from http://clinicaltrials.gov/ct2/show/NCT01353027

Safety Study of Single Administration Post-Exposure Prophylaxis Treatment for Ebola Virus

http://www.clinicaltrials.gov/ct2/show/NCT01353027?term=AVI+BIOPHARMA&rank=4

A similar trial with AVI-6003 to treat infection with the Marburg virus is being conducted at West Coast Clinical Trials in Cypress, California.

http://www.clinicaltrials.gov/ct2/show/NCT01353040?term=AVI+BIOPHARMA&rank=3

Uganda: Deadly Ebola Virus Confirmed Near Capital

]]> Comment on Success of Senegal’s first nationwide distribution of long-lasting insecticide-treated nets to children under five – contribution toward universal coverage by Grace http://www.mednewsafrica.com/2011/04/success-of-senegals-first-nationwide-distribution-of-long-lasting-insecticide-treated-nets-to-children-under-five-contribution-toward-universal-coverage/#comment-662 Grace Tue, 19 Apr 2011 21:01:03 +0000 http://www.mednewsafrica.com/?p=3467#comment-662 Such a relief to see that huge efforts are being made to fight malaria, especially for children. Let's continue distributing these LLINs to more areas in Africa. Freedom from Hunger has a Malaria campaign to help fight malaria. So please visit http://bit.ly/malaria_day_2011 so we can envision a future without malaria. Such a relief to see that huge efforts are being made to fight malaria, especially for children. Let’s continue distributing these LLINs to more areas in Africa. Freedom from Hunger has a Malaria campaign to help fight malaria. So please visit http://bit.ly/malaria_day_2011 so we can envision a future without malaria.

]]> Comment on Assessment of the protective effect of male circumcision from HIV infection and sexually transmitted diseases: evidence from 18 demographic and health surveys in sub-Saharan Africa. by Hugh7 http://www.mednewsafrica.com/2011/01/assessment-of-the-protective-effect-of-male-circumcision-from-hiv-infection-and-sexually-transmitted-diseases-evidence-from-18-demographic-and-health-surveys-in-sub-saharan-africa/#comment-14 Hugh7 Mon, 31 Jan 2011 02:45:03 +0000 http://www.mednewsafrica.com/?p=2661#comment-14 Looks like data mining. The words "to assess the protective effect of male circumcision" suggest the researchers had an agenda. The USAIDS report on what looks like the same data found "There appears to be no clear pattern of association between male circumcision and HIV prevalence. In 8 of 18 countries with data, as expected, HIV prevalence is lower among circumcised men, while in the remaining 10 countries HIV prevalence is higher among circumcised men" 'Torture the data and it will confess to anything,' as they say at Guantanamo Bay. Looks like data mining. The words “to assess the protective effect of male circumcision” suggest the researchers had an agenda.

The USAIDS report on what looks like the same data found “There appears to be no clear pattern of association between male circumcision and HIV prevalence. In 8 of 18 countries with data, as expected, HIV prevalence is lower among circumcised men, while in the remaining 10 countries HIV prevalence is higher among circumcised men”

‘Torture the data and it will confess to anything,’ as they say at Guantanamo Bay.

]]> Comment on Male circumcision for HIV prevention: current research and programmatic issues. by Hugh7 http://www.mednewsafrica.com/2010/11/male-circumcision-for-hiv-prevention-current-research-and-programmatic-issues/#comment-12 Hugh7 Wed, 01 Dec 2010 07:56:28 +0000 http://www.mednewsafrica.com/?p=2111#comment-12 typo: "while 64 did" typo: “while 64 did”

]]> Comment on Male circumcision for HIV prevention: current research and programmatic issues. by Hugh7 http://www.mednewsafrica.com/2010/11/male-circumcision-for-hiv-prevention-current-research-and-programmatic-issues/#comment-11 Hugh7 Wed, 01 Dec 2010 07:54:50 +0000 http://www.mednewsafrica.com/?p=2111#comment-11 They always say "reduces by about 60%". They never mention that the whole basis for that claim is 73 circumcised men who didn't get HIV while 63 did, less than two yeara after 5,400 men were circumcised and a similar number left alone. Now they multiply those few men by thoussands to make sweeping claims about circumcision saving the whole of Africa. There are many problems with those studies, beginning with the assumption that all the HIV was sexually transmitted. "Circumcision may also protect against HIV acquisition in men who have sex with men (MSM) and those who practice unprotected anal intercourse (either exclusively or predominantly), although these data are not consistent." That is just nonsense. Many studies have shown NO protection to MSMs, and those few that have only apply to very high-risk subsets, too small to be statistically significant. "Longitudinal studies among HIV discordant couples suggest that male circumcision may provide some direct long-term benefit to women, which may start after complete wound healing." On the contrary, the Wawer study (Lancet 374:9685, 229-37) suggested a much greater risk to women, but it was cut short before the effect of wound healing could be eliminated. The studies, and articles like this promoting them, are all written by the same handful of interconnected researchers, some of whom have indicated vested interests in circumcision. They always say “reduces by about 60%”. They never mention that the whole basis for that claim is 73 circumcised men who didn’t get HIV while 63 did, less than two yeara after 5,400 men were circumcised and a similar number left alone. Now they multiply those few men by thoussands to make sweeping claims about circumcision saving the whole of Africa. There are many problems with those studies, beginning with the assumption that all the HIV was sexually transmitted.

“Circumcision may also protect against HIV acquisition in men who have sex with men (MSM) and those who practice unprotected anal intercourse (either exclusively or predominantly), although these data are not consistent.” That is just nonsense. Many studies have shown NO protection to MSMs, and those few that have only apply to very high-risk subsets, too small to be statistically significant.

“Longitudinal studies among HIV discordant couples suggest that male circumcision may provide some direct long-term benefit to women, which may start after complete wound healing.” On the contrary, the Wawer study (Lancet 374:9685, 229-37) suggested a much greater risk to women, but it was cut short before the effect of wound healing could be eliminated.

The studies, and articles like this promoting them, are all written by the same handful of interconnected researchers, some of whom have indicated vested interests in circumcision.

]]> Comment on [Ocular manifestations in HIV/AIDS patients undergoing highly active antiretroviral treatment (HAART) in Togo] by HIV Symptoms In Men http://www.mednewsafrica.com/2010/07/ocular-manifestations-in-hivaids-patients-undergoing-highly-active-antiretroviral-treatment-haart-in-togo/#comment-6 HIV Symptoms In Men Sat, 27 Nov 2010 13:17:55 +0000 http://www.mednewsafrica.com/?p=527#comment-6 The studies for hiv/aids have been going on forever.. I wonder when they will come up with a cure for it The studies for hiv/aids have been going on forever.. I wonder when they will come up with a cure for it

]]> Comment on About MedNews by admin http://www.mednewsafrica.com/about/#comment-3 admin Thu, 21 Oct 2010 21:57:42 +0000 http://www.mednewsafrica.com/?page_id=2#comment-3 Thank you Dr. Bwonya. Appreciate that you find the website useful.If you have any suggestions on how we can make it better, we would be pleased to hear from you. Regards Francis Stevens George, Publisher Thank you Dr. Bwonya. Appreciate that you find the website useful.If you have any suggestions on how we can make it better, we would be pleased to hear from you.
Regards
Francis Stevens George, Publisher

]]> Comment on About MedNews by Dr Dan Bwonya http://www.mednewsafrica.com/about/#comment-2 Dr Dan Bwonya Thu, 21 Oct 2010 10:59:44 +0000 http://www.mednewsafrica.com/?page_id=2#comment-2 Your articles are informative Your articles are informative

]]>